Endocrine Abstracts (2007) 13 P338

The relative level and predictors of osteoporotic fracture in patients with treated thyroid dysfunction

Robert Flynn1, Sandra Bonellie2, Roland Jung3, Andrew Morris4, Thomas Macdonald4 & Graham Leese3


1Health Informatics Centre, Ninewells Hospital & Medical School, Dundee, United Kingdom; 2School of Accounting, Economics and Statistics, Napier University, Edinburgh, United Kingdom; 3Wards 1 & 2, Ninewells Hospital & Medical School, Dundee, United Kingdom; 4Department of Medicine & Therapeutics, Ninewells Hospital & Medical School, Dundee, United Kingdom.


Objectives: (1) to establish the relative level of osteoporotic fracture in the thyroid population compared to the general population, and (2) to establish whether osteoporotic fracture in patients receiving thyroxine was associated with plasma thyroid stimulating hormone (TSH) level or thyroxine dose.

Method: A database of clinical information from subjects with treated thyroid disease was linked to morbidity records describing all in-patient episodes of care due to osteoporotic fracture. Subjects were identified from a region of approximately 400,000 from January 1993 to December 2001. (1) Poisson regression was used to model relative fracture rate. (2) A Cox proportional hazards model was used to establish predictors of morbidity. Data were anonymised with permission obtained from the local ethics committee.

Results: There were 14,802 primary hypothyroid and 3,812 hyperthyroid patients. (1) After adjustment for age and sex, an increased rate of osteoporotic fracture was found for male primary hypothyroid patients (rate ratio 1.51 95% CI 1.13–2.01), and female hyperthyroid patients (RR 1.39; CI 1.19–1.62). (2) For subjects on thyroxine, females were at approximately twice the risk of osteoporotic fracture compared to males, whilst there was an approximate doubling in risk for every five years over the age of fifty. No association was found between low and suppressed TSH, however patients with ‘high’ TSH were at increased risk (hazard ratio 1.41; CI 1.10–1.80) – this was partly reduced by adjusting for ‘drug coverage’ – a measure of secondary compliance. Dose of thyroxine was not associated with fracture risk after adjustment for age and sex.

Conclusions: There is increased osteoporotic fracture in males with hypothyroidism and females with treated hyperthyroidism. Age and sex were both predictors of fracture in subjects on thyroxine. ‘High’ TSH concentration in such patients but not thyroxine dose was associated with increased risk. ‘High’ TSH was partly accounted for through poor compliance.

Article tools

My recent searches

No recent searches.